New techniques for imaging colorectal cancer: The use of MRI, PET and radioimmunoscintigraphy for primary staging and follow-up

British Medical Bulletin

Volumn 64, Issue , 2002, Pages 81-99

  Saunders, T H ^a   Mendes Ribeiro, H K ^a   Gleeson, F V ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1;

CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; FOLLOW UP; HUMAN; IMMUNOSCINTIGRAPHY; LIVER METASTASIS; METASTASIS; METASTASIS POTENTIAL; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RECTUM TUMOR; REVIEW; SOFT TISSUE CANCER; SURGICAL TECHNIQUE;

COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOIMMUNODETECTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0036031717     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/bmb/64.1.81     Document Type: Review

References (46)

1. Wahl R. Positron emission tomography: Applications in oncology. In: Murray IPC, Ell PJ. (eds) Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh: Churchill Livingstone, 1994; 911-40
2. Gordon BA, Flanagan FL, Dehdashti F. Whole body positron emission tomography: Normal variants, pitfalls and technical considerations. AJR Am J Roentgenol 1997; 169: 1675-80
3. Zealley IA, Skehan SJ, Rawlinson J, Coates G, Nahmias C, Somers S. Selection of patients for resection of hepatic metastases: Improved detection of extra hepatic disease with FDG PET. Radiographics 2001; 21: 55-69
4. Britton KE, Granowska M. The diagnostic role of radiolabelled antibodies. In: Murray IPC, Ell PJ. (eds) Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh: Churchill Livingstone, 1994; 871-92
5. 111Inlabelled monoclonal antibody against carcino-embryonic antigen in colorectal cancer and of some biological factors affecting its uptake. Int J Colorectal Dis 1989; 4: 97-108
6. Durdin H, Young S, Stewart LM et al. An epitope on carcino-embryonic antigen defined by the clinically relevant antibody PR1A3. Proc Natl Acad Sci USA 1994; 91: 4313 (Abstract)
7. Zwas ST, Goshen E, Rath P, Brenner H, Klein E, Ben-Ari G. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate carcino-embryonic antigen monoclonal antibody BW431/26. Cancer 1995; 76: 215-22
8. 111In-santumomab pendetide in patients with colorectal adenocarcinoma: Performance and impact on clinical management. Dis Colon Rectum 1994; 37: 129-37
9. 99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: Results of a pivotal phase 3 trial. J Clin Oncol 1996; 14: 2295-305
10. Hahn P. Biliary system, pancreas, spleen and alimentary tract. In: Stark DD, Bradley Jr WG. (eds) Magnetic Resonance Imaging. St Louis, MO: Mosby, 1999; 471-502
11. Spiessl B, Beahrs OH, Hermanek P et al. UICC TNM Atlas, 3rd Edn. New York, Springer, 1992
12. Brown G, Richards CJ, Newcombe RG et al. Rectal carcinoma: Thin section MR imaging for staging in 28 patients. Radiology 1999; 211: 215-22
13. Beets-Tan RG, Beets GL, Vliegen RF et al. Accuracy of magnetic resonance imaging in prediction of tumour free resection margin in rectal cancer surgery. Lancet 2001; 357: 497-504
14. Swedish Rectal Cancer Trial Investigators. Improved survival with pre-operative radiotherapy in resectable rectal carcinoma. N Engl J Med 1997; 336: 980-7
15. Urban M, Rosen HR, Hobling N et al. MR imaging for the pre-operative planning of sphincter saving surgery for tumours of the lower third of the rectum: Use of intravenous and endorectal contrast medium. Radiology 2000: 214: 503-8
16. Ng CS, Doyle TC, Dixon AK, Miller R, Arends MJ. Histopathological correlation of abnormal pericolic fat on CT in the assessment of colorectal cancer. Br J Radiol 2002; 75: 31-7
17. Zerhouni EA, Rutter C, Hamiliton SR et al. CT and MR imaging in the staging of colorectal carcinoma: Report of the Radiology Diagnostic Oncology Group II. Radiology 1996; 200: 443-51
18. Thompson WM, Halvorsen RA, Foster Jr WL, Roberts L, Gibbons R. Pre-operative and postoperative CT staging of rectosigmoid carcinoma. AJR Am J Roentgenol 1986; 146: 703-10
19. Hulsmans FJ, Tio TL, Fockens P, Bosma A, Tygat GN. Assessment of tumour infiltration depth in rectal cancer with transrectal sonography; caution is necessary. Radiology 1994; 190: 715-22
20. Schnall MD, Furth EE, Rosato EF, Kressel HY. Rectal tumour stage; correlation of endorectal MR imaging and pathologic findings. Radiology 1994; 190: 709-14
21. Wallengren NO, Holtas S, Andren-Sandberg A, Jonsson E, Kristofferson DT, McGill S. Rectal carcinoma: Double contrast MR imaging for pre-operative staging. Radiology 2000; 215: 108-14
22. Abdel Nabi H, Doerr RJ, Lamonica DM et al. Staging of primary colorectal carcinomas with fluorine-18-fluorodeoxyglucose whole body PET: Correlation with histopathologic and CT findings. Radiology 1998; 206: 755-60
23. Zheng G, Johnson RJ, Eddlestone B, James RD, Schofield PD. CT scanning in rectal carcinoma. J R Soc Med 1984; 77: 915-20
24. Lee JK, Heiken JP, Ling D et al. Magnetic resonance imaging of abdominal and pelvic lymphadenopathy. Radiology 1984; 153: 181-8
25. Harisinghani MG, Sani S, Weissleder R et al. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologic correlation. AJR Am J Roentgenol 1999; 172: 1347-51
26. 99m IMMU-4 monoclonal antibody scanning and CT. Radiology 1995; 197: 688-92
27. 111In-CYT-103 in the management of colon cancer. Am J Surg 1993;165:137-42
28. Falk PM, Gupta NC, Thoroson AG et al. Positron emission tomography for pre-operative staging of colorectal carcinoma. Dis Colon Rectum 1994; 37: 153-6
29. Whiteford MH, Whiteford HM, Ogunbiyi OA et al. Usefulness of FDG-PET scan in the assessment of suspected metastatic or recurrent adenocarcinoma of the colon and rectum. Dis Colon Rectum 2000; 43: 759-67
30. 18IF-FDG positron emission tomography on selection of patients for resection of hepatic colorectal metastases. Am J Surg 1999; 178: 282-7
31. Vitola JV, Delbeke D, Sandler MP et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996; 171: 21-6
32. 18IF-fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg 1994; 81: 1666-70
33. Soyer P, Laissy JP, Sibert A et al. Focal hepatic masses: Comparison of detection during arterial portography with MR imaging and CT. Radiology 1994; 190: 737-40
34. Valls C, Andia E, Sanchez A et al. Hepatic metastases from colorectal cancer: Pre-operative detection and assessment of respectability with helical CT. Radiology 2001; 218: 55-60
35. Schwartz LH, Gandras EJ, Colangelo SM, Ercolani MC, Paniecek DM. Prevalence and importance of small hepatic lesions found at CT in patients with cancer. Radiology 1999; 210: 71-4
36. Imam K, Bluemke DA. MR imaging in the evaluation of hepatic metastases. Magn Reson Imaging Clin North Am 2000; 8: 741-56
37. Outwater E, Tomaszewski JE, Daly JM, Kressel HY. Hepatic colorectal metastasis: Correlation of MR imaging and pathologic appearances. Radiology 1991; 180: 327-32
38. Seneterre E, Taourel P, Bouvier Y et al. Detection of hepatic metastases: Ferumoxides enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography. Radiology 1996; 200: 785-92
39. Hagspiel KD, Neidi KF, Eichenberger AC, Weder W, Marincek B. Detection of liver metastases: Comparison of superparamagnetic iron oxide enhanced and unenhanced MR at 1.5T with dynamic CT, intraoperative ultrasound and percutaneous ultrasound. Radiology 1995; 196: 471-8
40. 18IF-fluorodeoxyglucose in identifying operable colorectal cancer metastasis to the liver. Arch Surg 1996; 131: 703-7
41. Dicle O, Obuz F, Cakmacki H et al. Differentiation of recurrent rectal cancer and scarring with dynamic MR imaging. Br J Radiol 1999; 72: 1155-9
42. Kinkel K, Tardivon AA, Soyer P et al. Dynamic contrast enhanced subtraction versus T2 spin echo MR imaging in the follow up of colorectal neoplasm: A prospective study of 41 patients. Radiology 1996; 200: 453-8
43. Muller-Schimpfle M, Brix G, Layer G et al. Recurrent rectal cancer: Diagnosis with dynamic MR imaging. Radiology 1993; 189: 881-9
44. Ito K, Kato K, Tadokoro M et al. Recurrent rectal cancer and scar: Differentiation with PET and MR imaging. Radiology 1992; 182: 549-52
45. Johnson K, Baksh A, Young D, Martin Jr TE, Arnold M. Correlating computed tomography and positron emission tomography scan with operative findings in metastatic colorectal cancer. Dis Colon Rectum 2001; 44: 354-7
46. Flanagan FL, Dehdasti F, Ogunbiyi OA, Kodner IJ, Siegal BA. Utility of FDG PET for investigating unexplained CEA elevation in patients with colorectal cancer. Ann Surg 1998; 227: 319-23